Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2003
07/10/2003WO2003055980A2 Il-17 like molecules and uses thereof
07/10/2003WO2003055915A2 Human netrin receptor and uses thereof
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055911A2 Cystine-knot fold protein
07/10/2003WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003WO2003055906A1 Modified bacterial surface layer proteins
07/10/2003WO2003055905A2 Proteins of non typable haemophilus influenzae
07/10/2003WO2003055529A1 Dna vaccine for periodontal disease
07/10/2003WO2003055519A1 Medicinal agent and method for curing diseases accompanied with vascular dystonia
07/10/2003WO2003055517A1 Method for correcting immune response and medicinal agent
07/10/2003WO2003055516A1 Pecam-1 modulation
07/10/2003WO2003055515A1 Individualized anti-cancer antibodies
07/10/2003WO2003055514A1 Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
07/10/2003WO2003055513A2 Bacillus subtilis spores to stimulate the immune responses
07/10/2003WO2003055442A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003055439A2 Her2/neu target antigen and use of same to stimulate an immune response
07/10/2003WO2003008452A3 Bispecific monoclonal antibodies to il-12 and il-18 receptors
07/10/2003WO2003007880A3 Inhibition of behab cleavage and primary central nervous system (cns) tumors
07/10/2003WO2003004524A3 Apicomplexa parasites secreted proteins
07/10/2003WO2002100345A3 Vaccines, immunotherapeutics and methods of using the same
07/10/2003WO2002096937A3 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
07/10/2003WO2002092625A3 Moraxella(branhamella) catarrhalis antigens
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002046238A3 Rationally designed antibodies
07/10/2003WO2002043570A3 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
07/10/2003WO2002040541A3 Transporters and ion channels
07/10/2003WO2002036159A3 Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use
07/10/2003WO2002017962A3 Chemoprotectant for gastric toxicity
07/10/2003WO2002013845A3 Inflammation related g-protein coupled receptor
07/10/2003WO2002012281A3 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
07/10/2003WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor
07/10/2003WO2001089549A3 Therapeutic uses of il-1 receptor antagonist
07/10/2003WO2001089364A9 Hcv variants
07/10/2003US20030130498 Highly infectious rubella virus DNA constructs and methods of production
07/10/2003US20030130496 Immunoglobulins; cloning, amplifying and encoding by DNA sequences, polymerase chain reaction
07/10/2003US20030130495 G-protein coupled receptors, signal transduction pathways
07/10/2003US20030130493 Endothelial Differentiation Gene (Edg), neuroregulators, phospholipid metabolism, nervous systems
07/10/2003US20030130491 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130490 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins; extracellular
07/10/2003US20030130344 Noscapine derivatives as adjuvant compositions and methods of use thereof
07/10/2003US20030130324 Method for preventing or controlling cataract
07/10/2003US20030130216 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac disease
07/10/2003US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof
07/10/2003US20030130187 Porcine adenovirus type 3 genome
07/10/2003US20030130184 Using protein from papilloma virus; genetic engineering
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130180 Utilization of an aminopeptidase inhibitor
07/10/2003US20030129744 Bvdv virus-like particles
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129702 DNA encoding galanin GALR2 receptors and uses thereof
07/10/2003US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
07/10/2003US20030129652 Human sperm specific lysozyme-like proteins
07/10/2003US20030129650 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity
07/10/2003US20030129601 Selecting the sequences encoding essential molecules as regulatory nucleotidic sequences and proteins for the survival or the virulence of mycobacterium species
07/10/2003US20030129597 Inhibiting EG-1 to inhibit angiogenesis and metastasis
07/10/2003US20030129582 Method for determining early HCV seroconversion
07/10/2003US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier
07/10/2003US20030129233 Sustained release hydrophobic bioactive PLGA microspheres
07/10/2003US20030129207 Obtaining a biological sample from the patient, contacting the sample with a binding agent that binds to a polypeptide, detecting amount of bounded polypeptide, comparing it to a predetermined cut-off value to determine presence of cancer
07/10/2003US20030129206 Medicament for the immunotherapy of malignant tumours
07/10/2003US20030129205 Inducing presensitization of immune system towards an immunogen carrying lymphocytes epitope homologous to allergen; immunosuppressants
07/10/2003US20030129204 Vaccines against helminthic parasites
07/10/2003US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
07/10/2003US20030129201 Methods of preventing and treating flavivirus infection in animals
07/10/2003US20030129200 Inoculation using polymerases that have been deactivated using ultraviolet radiation or enzyme inhibitors such as azido dipyrodiazepinona and/or N-(4-chloro-3-(3-methyl-2-butenyloxy) phenyl)-2-methyl-3-furanocarbothiamide
07/10/2003US20030129199 Combined vaccine compositions
07/10/2003US20030129198 Methods to produce high levels of C. difficile toxins
07/10/2003US20030129197 Influenza vaccine
07/10/2003US20030129196 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
07/10/2003US20030129195 Use of heat shock proteins
07/10/2003US20030129187 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
07/10/2003US20030129185 Chimeric antibodies; lymphocytes; genetic engineering; for treatment of myeloma
07/10/2003US20030129184 Monoclonal antibody specific to polypeptide which induces interferon-gamma production
07/10/2003US20030129175 Gene therapy; heterogeneity tissue transcription; antitumor agents
07/10/2003US20030129171 Cloning mastitis gene; muscular disorders
07/10/2003US20030129161 Interleukin-12 as a veterinary vaccine adjuvant
07/10/2003US20030129141 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery
07/10/2003US20030129079 Method for protein-preserving purification of contaminated biological liquids
07/10/2003CA2511466A1 Bacillus subtilis spores to stimulate the immune responses
07/10/2003CA2472123A1 Proteins of non typable haemophilus influenzae
07/10/2003CA2471916A1 Modified bacterial surface layer proteins
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471297A1 Human netrin receptor and uses thereof
07/10/2003CA2471206A1 Individualized anti-cancer antibodies
07/10/2003CA2471131A1 An avian embryo particulate biomass for the production of virus antigens
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2471127A1 An antisense strategy to modulate estrogen receptor response (er.alpha. and/or er.beta.)
07/10/2003CA2471092A1 Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
07/10/2003CA2470781A1 Cystine-knot fold protein
07/10/2003CA2470696A1 Pecam-1 modulation
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2469690A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003CA2463738A1 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
07/10/2003CA2458751A1 Compositions and methods for the treatement of immune related diseases
07/09/2003EP1325957A2 Recombinant papilloma virus L1
1 ... 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 ... 1823